Sentien Biotechnologies, Inc.
- UEI
- NDAYRDKCMBJ7
- CAGE
- 59MH0
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | -$239,734 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sentien biotechnologies, INC.: r & d of EX vivo cell therapy | Office of the Assistant Secretary for Preparedness and Response | $510,265 | |
| Sbir phase i army 2011.2 log #11256002 | Medical Command (Army) | $99,974 |
Grant awards
Quick answers
Is Sentien Biotechnologies, Inc. registered in SAM.gov?
Sentien Biotechnologies, Inc.'s SAM.gov registration expired on April 3, 2023.
What is Sentien Biotechnologies, Inc.'s most recent federal award?
Sentien Biotechnologies, Inc.'s most recent federal contract award is Sentien biotechnologies, INC.: r & d of EX vivo cell therapy (75A50121C00072), from Office of the Assistant Secretary for Preparedness and Response, on August 18, 2021.
On GovTribe
See Sentien Biotechnologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors